These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 21834866

  • 1. An in vitro comparison of the effects of the iron-chelating agents, CP94 and dexrazoxane, on protoporphyrin IX accumulation for photodynamic therapy and/or fluorescence guided resection.
    Blake E, Allen J, Curnow A.
    Photochem Photobiol; 2011; 87(6):1419-26. PubMed ID: 21834866
    [Abstract] [Full Text] [Related]

  • 2. The hydroxypyridinone iron chelator CP94 can enhance PpIX-induced PDT of cultured human glioma cells.
    Blake E, Curnow A.
    Photochem Photobiol; 2010; 86(5):1154-60. PubMed ID: 20573043
    [Abstract] [Full Text] [Related]

  • 3. The effects of protoporphyrin IX-induced photodynamic therapy with and without iron chelation on human squamous carcinoma cells cultured under normoxic, hypoxic and hyperoxic conditions.
    Blake E, Allen J, Curnow A.
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):575-82. PubMed ID: 24284114
    [Abstract] [Full Text] [Related]

  • 4. An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy.
    Anayo L, Magnussen A, Perry A, Wood M, Curnow A.
    Lasers Surg Med; 2018 Jul; 50(5):552-565. PubMed ID: 29603761
    [Abstract] [Full Text] [Related]

  • 5. Biochemical manipulation via iron chelation to enhance porphyrin production from porphyrin precursors.
    Curnow A, Pye A.
    J Environ Pathol Toxicol Oncol; 2007 Jul; 26(2):89-103. PubMed ID: 17725535
    [Abstract] [Full Text] [Related]

  • 6. Direct comparison of delta-aminolevulinic acid and methyl-aminolevulinate-derived protoporphyrin IX accumulations potentiated by desferrioxamine or the novel hydroxypyridinone iron chelator CP94 in cultured human cells.
    Pye A, Curnow A.
    Photochem Photobiol; 2007 Jul; 83(3):766-73. PubMed ID: 17576385
    [Abstract] [Full Text] [Related]

  • 7. The efficacy of an iron chelator (CP94) in increasing cellular protoporphyrin IX following intravesical 5-aminolaevulinic acid administration: an in vivo study.
    Chang SC, MacRobert AJ, Porter JB, Bown SG.
    J Photochem Photobiol B; 1997 Apr; 38(2-3):114-22. PubMed ID: 9203372
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of methyl-aminolevulinate photodynamic therapy by iron chelation with CP94: an in vitro investigation and clinical dose-escalating safety study for the treatment of nodular basal cell carcinoma.
    Pye A, Campbell S, Curnow A.
    J Cancer Res Clin Oncol; 2008 Aug; 134(8):841-9. PubMed ID: 18239941
    [Abstract] [Full Text] [Related]

  • 9. The hydroxypyridinone iron chelator CP94 increases methyl-aminolevulinate-based photodynamic cell killing by increasing the generation of reactive oxygen species.
    Dogra Y, Ferguson DCJ, Dodd NJF, Smerdon GR, Curnow A, Winyard PG.
    Redox Biol; 2016 Oct; 9():90-99. PubMed ID: 27454766
    [Abstract] [Full Text] [Related]

  • 10. Experimental investigation of a combinational iron chelating protoporphyrin IX prodrug for fluorescence detection and photodynamic therapy.
    Magnussen A, Reburn C, Perry A, Wood M, Curnow A.
    Lasers Med Sci; 2022 Mar; 37(2):1155-1166. PubMed ID: 34218351
    [Abstract] [Full Text] [Related]

  • 11. Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug.
    Curnow A, Perry A, Wood M.
    Photodiagnosis Photodyn Ther; 2019 Mar; 25():157-165. PubMed ID: 30553949
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of 5-aminolaevulinic acid-induced photodynamic therapy in normal rat colon using hydroxypyridinone iron-chelating agents.
    Curnow A, McIlroy BW, Postle-Hacon MJ, Porter JB, MacRobert AJ, Bown SG.
    Br J Cancer; 1998 Nov; 78(10):1278-82. PubMed ID: 9823966
    [Abstract] [Full Text] [Related]

  • 13. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
    Middelburg TA, de Bruijn HS, van der Ploeg-van den Heuvel A, Neumann HA, Robinson DJ.
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
    [Abstract] [Full Text] [Related]

  • 14. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma.
    Campbell SM, Morton CA, Alyahya R, Horton S, Pye A, Curnow A.
    Br J Dermatol; 2008 Aug; 159(2):387-93. PubMed ID: 18544077
    [Abstract] [Full Text] [Related]

  • 15. Novel Iron-Chelating Prodrug Significantly Enhanced Fluorescence-Mediated Detection of Glioma Cells Experimentally In Vitro.
    Reburn C, Gawthorpe G, Perry A, Wood M, Curnow A.
    Pharmaceutics; 2023 Nov 24; 15(12):. PubMed ID: 38140009
    [Abstract] [Full Text] [Related]

  • 16. Low-dose arsenic trioxide enhances 5-aminolevulinic acid-induced PpIX accumulation and efficacy of photodynamic therapy in human glioma.
    Wang C, Chen X, Wu J, Liu H, Ji Z, Shi H, Gao C, Han D, Wang L, Liu Y, Yang G, Fu C, Li H, Zhang D, Liu Z, Li X, Yin F, Zhao S.
    J Photochem Photobiol B; 2013 Oct 05; 127():61-7. PubMed ID: 23962849
    [Abstract] [Full Text] [Related]

  • 17. Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification.
    Tyrrell J, Campbell SM, Curnow A.
    Photodiagnosis Photodyn Ther; 2011 Mar 05; 8(1):30-8. PubMed ID: 21333932
    [Abstract] [Full Text] [Related]

  • 18. Topical applications of iron chelators in photosensitization.
    Juzeniene A, Juzenas P, Iani V, Moan J.
    Photochem Photobiol Sci; 2007 Dec 05; 6(12):1268-74. PubMed ID: 18046481
    [Abstract] [Full Text] [Related]

  • 19. Calcitriol enhances 5-aminolevulinic acid-induced fluorescence and the effect of photodynamic therapy in human glioma.
    Chen X, Wang C, Teng L, Liu Y, Chen X, Yang G, Wang L, Liu H, Liu Z, Zhang D, Zhang Y, Guan H, Li X, Fu C, Zhao B, Yin F, Zhao S.
    Acta Oncol; 2014 Mar 05; 53(3):405-13. PubMed ID: 24032442
    [Abstract] [Full Text] [Related]

  • 20. Polymeric iron chelators for enhancing 5-aminolevulinic acid-induced photodynamic therapy.
    Nomoto T, Komoto K, Nagano T, Ishii T, Guo H, Honda Y, Ogura SI, Ishizuka M, Nishiyama N.
    Cancer Sci; 2023 Mar 05; 114(3):1086-1094. PubMed ID: 36341512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.